Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Vizsgálati helyszín

Addenbrookes Hospital

Cambridge, CB2 0QQ, Egyesült KirályságMég nincs intézményhez kötve

36futó vizsgálat
18lezárt vizsgálat

Az itteni vizsgálatok

Miről szól a helyszín 54 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek: Gyermekkori daganatok6 vizsgálat
Colitis ulcerosa4 vizsgálat
Hasnyálmirigyrák4 vizsgálat
Lupus (SLE)4 vizsgálat
Petefészekrák4 vizsgálat
Tüdőrák4 vizsgálat
Vastagbélrák4 vizsgálat
Akut mieloid leukémia (AML)3 vizsgálat
Melanóma3 vizsgálat
Stroke (szélütés)3 vizsgálat
Szarkóma3 vizsgálat
Akut limfoid leukémia (ALL)2 vizsgálat
és még 35
Fázis: 3. fázis22 vizsgálat
2. fázis11 vizsgálat
1. fázis3 vizsgálat
1/2. fázis3 vizsgálat
2/3. fázis1 vizsgálat
Állapot: Fut, nem toboroz19 vizsgálat
Lezárult16 vizsgálat
Toboroz15 vizsgálat
Leállították2 vizsgálat
Meghívásos bevonás1 vizsgálat
Még nem toboroz1 vizsgálat
Fő szponzor: Hoffmann-La Roche11 vizsgálat
Janssen Research & Development, LLC7 vizsgálat
Royal Marsden NHS Foundation Trust3 vizsgálat
University College, London3 vizsgálat
Amgen2 vizsgálat
és még 26

Futó vizsgálatok

Toboroz
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
NCT07438496· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus Study
NCT07913919· University of Cambridge· Forrás
Contact: Thomas AJ Bond, MBChB, BMedSci
Fut, nem toboroz
UK ENcorafenib and BInimetinib Real-world Study in Melanoma
NCT07022457· Pierre Fabre Ltd· Forrás
Fut, nem toboroz
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433· 3. fázis· Amgen· Forrás
Toboroz
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798· 2. fázis· Amgen· Forrás
Toboroz
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT06852222· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819878· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
NCT06812325· 3. fázis· Viridian Therapeutics, Inc.· Forrás
Toboroz
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
NCT06435156· 2. fázis· University of Dundee· Forrás
Contact: Ify Mordi, MBChB, MD
Toboroz
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
NCT06715449· 2/3. fázis· University of East Anglia· Forrás
Contact: Vassilios S. Vassiliou, PhD
Toboroz
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
NCT06672549· 3. fázis· Eli Lilly and Company· Forrás
Contact: Ken Ong (principal investigator)
Toboroz
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
NCT07334301· 1/2. fázis· University of Birmingham· Forrás
Contact: Principal Investigator
Fut, nem toboroz
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06589986· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus
NCT06333483· 1. fázis· Autolus Limited· Forrás
Fut, nem toboroz
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
NCT06046222· 2. fázis· NS Pharma, Inc.· Forrás
Fut, nem toboroz
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
NCT05968326· 2. fázis· Genentech, Inc.· Forrás
Fut, nem toboroz
Avacostar - (PASS)
NCT05897684· Vifor Fresenius Medical Care Renal Pharma· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
NCT05797610· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease
NCT05686551· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
NCT04920708· 2. fázis· Royal Marsden NHS Foundation Trust· Forrás
Toboroz
Ultrafast Whole Genome Sequencing for Childhood Cancer
NCT07201038· University of Cambridge· Forrás
Contact: Victoria Joslin
Toboroz
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
NCT05613023· 3. fázis· Institute of Cancer Research, United Kingdom· Forrás
Contact: Kamalram Thippu Jayaprakash
Fut, nem toboroz
NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer
NCT05197322· 2. fázis· University College, London· Forrás
Fut, nem toboroz
CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)
NCT04678869· University College, London· Forrás
Toboroz
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
NCT04929223· 1. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Long-term Extension Study of Ustekinumab in Pediatric Participants
NCT05092269· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Methods of T Cell Depletion Trial (MoTD)
NCT04888741· 2. fázis· University of Birmingham· Forrás
Contact: MoTD Trial
Meghívásos bevonás
Minimizing Facial Nerve Stimulation in Cochlear Implants
NCT04161261· Cambridge University Hospitals NHS Foundation Trust· Forrás
Fut, nem toboroz
LITMUS Imaging Study
NCT05479721· University of Oxford· Forrás
Toboroz
Renal Adjuvant MultiPle Arm Randomised Trial
NCT03288532· 3. fázis· University College, London· Forrás
Contact: Sarah Welsh (principal investigator)
Fut, nem toboroz
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
NCT03522246· 3. fázis· pharmaand GmbH· Forrás
Fut, nem toboroz
A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT03462719· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
NCT04050345· Royal Marsden NHS Foundation Trust· Forrás
Contact: Ultan McDermott (principal investigator)
Fut, nem toboroz
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
NCT02568267· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
NCT02446444· 3. fázis· University of Sydney· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Gyermekkori daganatok3 toboroz
Lupus (SLE)3 toboroz
Akut mieloid leukémia (AML)2 toboroz
Vastagbélrák2 toboroz
1-es típusú cukorbetegség1 toboroz
2-es típusú cukorbetegség1 toboroz
Akut limfoid leukémia (ALL)1 toboroz
Colitis ulcerosa1 toboroz
Crohn-betegség1 toboroz
Elhízás1 toboroz
Hearing loss1 toboroz
Hodgkin-limfóma1 toboroz
Krónikus limfoid leukémia (CLL)1 toboroz
Krónikus mieloid leukémia (CML)1 toboroz
Mielodiszplasztikus szindróma (MDS)1 toboroz
Mielóma multiplex1 toboroz
Mieloproliferatív neopláziák1 toboroz
Neuroblasztóma1 toboroz
Pitvarfibrilláció1 toboroz
Prosztatarák1 toboroz
Rheumatoid arthritis1 toboroz
Stroke (szélütés)1 toboroz
Szívelégtelenség1 toboroz
Vesedaganat1 toboroz

Lezárt vizsgálatok

Lezárult
A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
NCT06618001· 1. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
NCT06667414· Hoffmann-La Roche· Forrás
Leállították
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
NCT05949632· 1/2. fázis· Incyte Corporation· Forrás
Lezárult
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06049017· 2. fázis· Janssen Research & Development, LLC· Forrás
Leállították
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer
NCT04698915· 2. fázis· Galera Therapeutics, Inc.· Forrás
Lezárult
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy
NCT04660344· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
Optimal Post Tpa-Iv Monitoring in Ischemic Stroke
NCT03734640· Craig Anderson· Forrás
Lezárult
Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer
NCT04128332· CCTU- Cancer Theme· Forrás
Lezárult
Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy
NCT04471428· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
NCT04543617· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR
NCT04295577· Royal Marsden NHS Foundation Trust· Forrás
Lezárult
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
NCT03782207· Hoffmann-La Roche· Forrás
Lezárult
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])
NCT03517449· 3. fázis· Eisai Inc.· Forrás
Lezárult
BT1718 in Patients with Advanced Solid Tumours.
NCT03486730· 1/2. fázis· Cancer Research UK· Forrás
Lezárult
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)
NCT03370913· 3. fázis· BioMarin Pharmaceutical· Forrás
Lezárult
Repeatability and Reproducibility of Multiparametric MRI
NCT03743272· Perspectum· Forrás
Lezárult
Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke
NCT02898610· 3. fázis· University College Dublin· Forrás
Lezárult
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma
NCT01909453· 3. fázis· Pfizer· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 13.